Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the history of COVID-19 confirmed in accordance with the diagnosis and treatment plan of COVID-19(trial seventh edition); 2. Meet the discharge standards of COVID-19(trial seventh edition); 3. Meet the diagnosis standard of qi deficiency and phlegm stasis syndrome; 4. Patients aged 18-70 years old, 28 days after discharge, still have abnormal manifestations on lung CT; 5. Patients willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with primary and secondary cardiovascular, cerebrovascular, renal, endocrine, neurological and blood system diseases, tumors and tuberculosis; 2. Patients who have participated in or are participating in other clinical trials within one month; 3. Patients with mental disorders who can not express their feelings; 4. There are other situations that are not suitable to be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung CT Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| COVID-19 symptom score;Integral evaluation of qi deficiency and phlegm stasis syndrome;Pulmonary function assessment;St George's respiratory questionnaire score; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine